Mark T. Iwicki

Insider Reports History

Location
84 Waterford Drive, Marlborough, MA
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark T. Iwicki:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Director Common Stock 9.4K $422K $44.92 Jun 3, 2025 Direct
Q32 Bio Inc. Director Stock Option (Right to Buy) 53.5K $343K $13.42 Oct 23, 2025 Direct
KALA BIO, Inc. Director Common Stock 104K $212K $2.05 Oct 23, 2025 Direct
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Direct
Merus N.V. Director Share Option (right to buy) 13.2K $120K $13.52 May 22, 2025 Direct
Third Harmonic Bio, Inc. Director Common Stock 0 $0 $5.43 Aug 11, 2025 Direct
Inhibikase Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 602K Feb 21, 2025 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 26K Jun 8, 2024 Direct
KALA BIO, Inc. Director Stock Option (right to buy) 5.45K Jun 15, 2025 Direct
Third Harmonic Bio, Inc. Director Stock Option 0 Aug 11, 2025 Direct

Insider Reports Filed by Mark T. Iwicki

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Q32 Bio Inc. Oct 23, 2025 1 $0 4 Oct 27, 2025 Director
KALA KALA BIO, Inc. Oct 23, 2025 1 -$125K 4 Oct 24, 2025 Director
THRD Third Harmonic Bio, Inc. Aug 11, 2025 2 $0 4 Aug 14, 2025 Director
KALA KALA BIO, Inc. Jun 24, 2025 1 -$53K 4 Jun 26, 2025 Director
KALA KALA BIO, Inc. Jun 15, 2025 2 $0 4 Jun 17, 2025 Director
KALA KALA BIO, Inc. Jun 3, 2025 1 -$40.6K 4/A Jun 5, 2025 Director
AKRO Akero Therapeutics, Inc. Jun 3, 2025 1 $0 4 Jun 5, 2025 Director
MRUS Merus N.V. May 22, 2025 1 $0 4 May 27, 2025 Director
QTTB Q32 Bio Inc. Feb 24, 2025 6 $0 4 Feb 26, 2025 Director
IKT Inhibikase Therapeutics, Inc. Feb 21, 2025 1 $0 4/A Jul 2, 2025 Chief Executive Officer, Director
IKT Inhibikase Therapeutics, Inc. Feb 14, 2025 2 $0 4 Feb 19, 2025 Chief Executive Officer, Director
IKT Inhibikase Therapeutics, Inc. Feb 14, 2025 0 $0 3 Feb 19, 2025 Chief Executive Officer, Director
KALA KALA BIO, Inc. Jan 6, 2025 3 -$44.1K 4 Jan 7, 2025 CHIEF EXECUTIVE OFFICER, Director
KALA KALA BIO, Inc. Jun 26, 2024 1 -$72K 4 Jun 27, 2024 CHIEF EXECUTIVE OFFICER, Director
AKRO Akero Therapeutics, Inc. Jun 8, 2024 1 $0 4 Jun 11, 2024 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
AVTE Aerovate Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
KALA KALA BIO, Inc. May 31, 2024 1 -$45K 4 Jun 3, 2024 CHIEF EXECUTIVE OFFICER, Director
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director
KALA KALA BIO, Inc. Jan 4, 2024 3 -$30.5K 4 Jan 5, 2024 CHIEF EXECUTIVE OFFICER, Director
AKRO Akero Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jun 22, 2023 2 $0 4 Jun 23, 2023 CHIEF EXECUTIVE OFFICER, Director
MRUS Merus N.V. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
THRD Third Harmonic Bio, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
KALA Kala Pharmaceuticals, Inc. May 31, 2023 11 $0 4 Jun 2, 2023 CHIEF EXECUTIVE OFFICER, Director
MRUS Merus N.V. Apr 14, 2023 4 $535K 4 Apr 17, 2023 Director
KALA Kala Pharmaceuticals, Inc. Mar 14, 2023 1 $0 4 Mar 15, 2023 CHIEF EXECUTIVE OFFICER, Director
THRD Third Harmonic Bio, Inc. Mar 6, 2023 4 $0 4 Mar 8, 2023 Director
KALA Kala Pharmaceuticals, Inc. Jan 4, 2023 2 -$5.65K 4 Jan 6, 2023 CHIEF EXECUTIVE OFFICER, Director
KALA Kala Pharmaceuticals, Inc. Oct 26, 2022 1 -$3.66K 4 Oct 28, 2022 CHIEF EXECUTIVE OFFICER, Director
THRD Third Harmonic Bio, Inc. Oct 26, 2022 1 $0 4 Oct 27, 2022 Director
THRD Third Harmonic Bio, Inc. Sep 14, 2022 0 $0 3 Sep 14, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jun 27, 2022 1 -$2.95K 4 Jun 29, 2022 CHIEF EXECUTIVE OFFICER, Director
AVTE Aerovate Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
AKRO Akero Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
MRUS Merus N.V. May 31, 2022 1 $0 4 Jun 2, 2022 Director
KALA Kala Pharmaceuticals, Inc. Jan 3, 2022 2 -$12.4K 4 Jan 5, 2022 CHIEF EXECUTIVE OFFICER, Director
KALA Kala Pharmaceuticals, Inc. Oct 26, 2021 1 -$49.7K 4 Oct 28, 2021 CHIEF EXECUTIVE OFFICER, Director
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Director
KALA Kala Pharmaceuticals, Inc. Jun 28, 2021 1 -$43.8K 4 Jun 29, 2021 CHIEF EXECUTIVE OFFICER, Director
AKRO Akero Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director
MRUS Merus N.V. May 28, 2021 1 $0 4 Jun 2, 2021 Director
AVTE Aerovate Therapeutics, Inc. Apr 2, 2021 3 $0 4 Jul 1, 2021 Director